Showing results (2151-2160 of 11,100) with videos related to
Sort By:
Pageof 1,110
Biological & Pharmaceutical Bulletin|August 4, 2015
Effects of a Tricaprylin Emulsion on Anti-glomerular Basement Membrane Glomerulonephritis in Rats: In Vivo and in Silico StudiesNing Liu, Junfeng Shi, Ying Xiao, et al.Biological & Pharmaceutical Bulletin|August 4, 2015
Rapid Fluorescent Detection Assay for Human Parainfluenza VirusesTadanobu Takahashi, Maiko Takano, Yuuki Kurebayashi, et al.Biological & Pharmaceutical Bulletin|August 4, 2015
Evaluation of Duloxetine as Micronuclei Inducer in an Acute and a Subchronic Assay in MouseEduardo Madrigal-Bujaidar, Isela Álvarez-González, Eduardo Osiris Madrigal-Santillán, et al.Biological & Pharmaceutical Bulletin|August 8, 2015
High Expression Levels of Trigger Receptor Expressed on Myeloid Cells-1 on Neutrophils Associated with Increased Severity of Acute Pancreatitis in MiceMulin Liu, Wei Wu, Qun Zhao, et al.Biological & Pharmaceutical Bulletin|September 11, 2015
Tabletting Process of Pellets Containing Bioactive Fraction DLBS1033F Isolated from Lumbricus rubellus: Challenge and StrategyGabriela Christy, Raymond Rubianto Tjandrawinata, Heni RachmawatiBiological & Pharmaceutical Bulletin|February 11, 2016
Protective Effect of Gomisin N against Endoplasmic Reticulum Stress-Induced Hepatic SteatosisMin-Kyung Jang, Ye-Rang Yun, Seon Hoo Kim, et al.Biological & Pharmaceutical Bulletin|February 3, 2016
Neuroprotective Effect of Ocular Hypotensive Drugs: Latanoprost/Timolol in Combination Are More Effective than Each as Monotherapy in RGC-5Shinichiro Fuma, Masamitsu Shimazawa, Tomoyo Imamura, et al.Biological & Pharmaceutical Bulletin|February 3, 2016
Effects of Glycated Whey Protein Concentrate on Pro-inflammatory Cytokine Expression and Phagocytic Activity in RAW264.7 MacrophagesSu-Hyun Chun, Hyun Ah Lee, Keon Bong Lee, et al.Biological & Pharmaceutical Bulletin|February 3, 2016
Design and Synthesis of New Phthalazinone Derivatives Containing Benzyl Moiety with Anticipated Antitumor ActivityMagda Ismail Marzouk, Soheir Ahmad Shaker, Aisha Ali Abdel Hafiz, et al.Biological & Pharmaceutical Bulletin|February 3, 2016
Eculizumab Dosing Intervals Longer than 17 Days May Be Associated with Greater Risk of Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal HemoglobinuriaHirokazu Nakayama, Kensuke Usuki, Hirotoshi Echizen, et al.Pageof 1,110